Fifth Eye Receives FDA Clearance for Hemodynamic Monitoring Device

Fifth Eye, a provider of intuitive real-time clinical analytics, today announced the U.S. Food and Drug Administration (FDA) has granted De Novo classification for its Analytic for Hemodynamic Instability (AHI).